Joanne Filicko-O’Hara

Author

Also Known As

Dr. Joanne Filicko-O'Hara, J Filicko-O'Hara, J Filicko-O’Hara, J. Filicko-O'Hara, J.E. Filicko-O'Hara, Joanne E. Filicko-O'Hara, Joanne Filicko-O'Hara, Joanne Filicko-O'hara, Joanne Filicko-OHara, Joanne Filicko-Ohara

109

Publications

476

Citations

H-Index

Concepts

All Affiliations

Thomas Jefferson University Sidney Kimmel Cancer Center Thomas Jefferson University Hospital University of Pennsylvania Hackensack University Medical Center

About

Joanne Filicko-O’Hara is an author at Thomas Jefferson University specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	170
2	Immunology	5	5	153
3	Health Sciences	4	4	134
4	Cellular Therapies	3	3	87
5	Blood Transplantation	2	2	46

Joanne Filicko-O’Hara

Publications

355

Citations

H-Index

Page 1

	Year	Citations
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing Dolores Grosso, Matthew Carabasi, Joanne Filicko-O’Hara, Blood	2011	75
Clostridium Difficile Colonization and Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation Jackrapong Bruminhent, Zixuan Wang, Carol Hu, Biology of Blood and Marrow Transplantation	2014	75
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Haematologica ImmunologyPathologyMetronomic ChemotherapyFrontline TreatmentImmunotherapy	2020	51
A Two-Step Approach to Myeloablative Haploidentical Transplantation: Low Nonrelapse Mortality and High Survival Confirmed in Patients with Earlier Stage Disease Dolores Grosso, Sameh Gaballa, Önder Alpdoğan, Biology of Blood and Marrow Transplantation Cell TherapyLow Nonrelapse MortalityTransplantationMarrow TransplantationNonrelapse Mortality	2014	41
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation Sameh Gaballa, Neil Palmisiano, Önder Alpdoğan, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyTwo-step Haploidentical VersusImmunotherapyTransplantation Option	2015	29
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition Margaret Kasner, Rosemarie Mick, Grace R. Jeschke, Investigational New Drugs Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaImmunologyPharmacology	2018	19
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization Dolores Grosso, Eugene H. Johnson, Beth Colombe, Bone Marrow Transplantation Cell TherapyTransplantationMarrow TransplantationBone Marrow FailureAcquired Uniparental Disomy	2017	17
Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: a new paradigm for designer allogeneic blood and marrow transplantation Thea M. Friedman, Kira Goldgirsh, Stephanie Berger, Blood	2008	13
Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival Parameswaran Hari, Donna Reece, Jasleen K. Randhawa, Bone Marrow Transplantation Hematological MalignancyTransplantationMedicineImmunologyHematology	2018	13
The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation Dolores Grosso, Benjamin E. Leiby, Matthew Carabasi, Frontiers in Oncology	2019	12

Page 1